Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Randomized Experiments01:13

Randomized Experiments

6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K
Cluster Sampling Method01:20

Cluster Sampling Method

11.9K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
11.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

183
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
183
Hazard Ratio01:12

Hazard Ratio

120
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
120
Sampling Plans01:23

Sampling Plans

181
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
181
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London population.

medRxiv : the preprint server for health sciences·2026
Same author

Implementation of the VIVALDI Social Care data pipeline for monitoring and research of infections in care homes for older adults in the UK.

International journal of medical informatics·2026
Same author

CRT-Estimands Framework: consensus based extension of the ICH E9(R1) addendum for cluster randomised trials.

BMJ (Clinical research ed.)·2026
Same author

The impacts of introducing online postal self-sampling for sexually transmitted infections on the sustainability and equity of sexual health systems: lessons learned from a multi-method UK-wide realist evaluation.

BMC medicine·2026
Same author

Corrigendum to "Sexually transmitted infection testing and key outcomes following implementation of online postal self-sampling into sexual health services in England: a retrospective observational study of routinely collected service-level healthcare data" Lancet Reg Health Eur. 2025 Nov 29;61:101541.

The Lancet regional health. Europe·2026
Same author

E le Saua le Alofa (Love shouldn't hurt): exploring the acceptability, feasibility and potential impact of a co-developed intervention to prevent violence against women in Samoa.

BMC public health·2026
Same journal

When financial audits prescribe quality and safety in healthcare.

Journal of epidemiology and population health·2026
Same journal

Ageing behind bars: Safeguarding the health and dignity of older people in prison.

Journal of epidemiology and population health·2026
Same journal

National Congress of Clinical Epidemiology (EPICLIN) - 20th edition.

Journal of epidemiology and population health·2026
Same journal

Corrigendum to "Follow-up of cancer incidence associated with smoke-related PM2.5 exposure due to a coal mine fire" [J Epidemiol Popul Health 2025;73(6):203148].

Journal of epidemiology and population health·2026
Same journal

Predicting hepatocellular carcinoma in people with hepatitis B: a comparison between Cox proportional hazard and machine learning models.

Journal of epidemiology and population health·2026
Same journal

Area-based socioeconomic inequalities in cervical cancer screening coverage in France.

Journal of epidemiology and population health·2026
查看所有相关文章

相关实验视频

Updated: Jul 1, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

508

应该如何分析一个集群随机试验?

Laurent Billot1, Andrew Copas2, Clemence Leyrat3

  • 1The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Journal of epidemiology and population health
|March 13, 2024
PubMed
概括
此摘要是机器生成的。

集群随机试验需要考虑集群内相关性,以确保准确的结果. 本文详细介绍了分析标准和高级集群试验设计的方法,解决了小样本大小和缺失数据的问题.

关键词:
分析 分析 分析集群交叉试验 集群交叉试验集群随机试验的随机试验.阶梯试验的试验.

更多相关视频

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K

相关实验视频

Last Updated: Jul 1, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

508
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

5.9K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.1K

科学领域:

  • 生物统计学 生物统计学
  • 流行病学 流行病学
  • 临床试验 临床试验

背景情况:

  • 同一个集群内的个体在集群随机试验中表现出类似的结果.
  • 忽视集群内相关性导致集群试验中不准确的统计推断.

研究的目的:

  • 概述分析集群随机试验的原则.
  • 详细说明计算集群内部相关性的方法.
  • 解决先进的设计,如阶梯和集群交叉试验,以及小样本大小和缺失数据等问题.

主要方法:

  • 对集群随机试验的统计分析原则.
  • 量化和调整集群内部相关性的方法.
  • 针对阶梯和集群交叉设计的分析技术的调整.
  • 在集群试验中管理小样本规模和缺失数据的策略.

主要成果:

  • 对集群随机试验的准确分析需要考虑集群内相关性.
  • 已建立的方法允许在复杂的集群试验设计中进行正确的推断.
  • 现有技术可以应对诸如小样本和缺失数据等挑战.

结论:

  • 适当的统计分析对于集群随机试验中的有效结果至关重要.
  • 描述的原则和方法支持对各种集群试验设计进行可靠的分析.
  • 解决集群内部的相关性和数据挑战可以确保可靠的科学结论.